Pharmaceutical composition for treating equine cestodiasis

A technology of animal tapeworms and equine genus, applied in the direction of drug combination, pharmaceutical formula, anti-infective drugs, etc., can solve the problem of drug resistance of tapeworms, and achieve the effect of high cure rate, wide sources and simple preparation process

Inactive Publication Date: 2014-05-21
QINGDAO DERUI JUNFA BIOLOGY TECH +2
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Niclosamide is generally used for clinical treatment, but long-term use will cause tapeworms to develop drug resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] The present invention also provides a preparation method of any one of the above-mentioned Chinese medicine compositions for treating equine taeniasis, the preparation method of the Chinese medicine composition comprises the following steps,

[0035] In the first step, the components are mixed in proportion and pulverized into powder;

[0036] In the second step, the powder obtained in the first step is added to cold water and soaked for 6 hours to 12 hours, decocted with a slow fire for 3 hours to 5 hours, and the decoction is filtered to obtain the first filtrate. The quality of the powder is 2 to 4 times that of the powder obtained in the first step;

[0037] In the third step, add the filter residue obtained by the second step of filtration into cold water again, decoct with a slow fire for 2 hours to 4 hours, and filter to obtain the second filtrate. 4 times;

[0038] In the fourth step, the first filtrate obtained in the second step is mixed with the second filt...

Embodiment 1

[0057] Toosendan 25g, Bupleurum 20g, Lychee seed 20g, Fennel 20g, Frankincense 10g, Notopterygium 10g and Duhuo 25g. Mix and crush into powder with a particle size of 200 mesh; add 100ml rice wine to the powder and mix well. When in use, pour orally.

Embodiment 2

[0059] Toosendan 24g, Bupleurum 19g, Lychee core 19g, Fennel 20g, Frankincense 9g, Notopterygium 9g, Duhuo 24g and Evodia 18g. Mix and crush into powder with a particle size of 180 mesh; add 90ml rice wine to the powder and mix well. When in use, pour orally.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pharmaceutical composition for treating equine cestodiasis, which comprises the following active pharmaceutical ingredients: toosendan fruit, radix bupleuri, lychee seed, fennel, frankincense, notopterygium root and heracleum hemsleyanum michaux. By using the treatment principles of warming the middle-jiao, dispelling cold, invigorating qi and invigorating vital function, the composition has the advantages of reasonable formula, simple preparation technique and wide application range. The composition is prepared from pure Chinese medicinal herbs, and thus, has the advantages of wide sources, low cost, high cure rate, no drug residue and no toxic or side effect; and especially, superfine grinding maximally destroys the plant cell walls, so the composition overcomes the defects of high coarse fiber content and difficulty in leaching effective components in the traditional medicinal powder, and can be absorbed by horses more easily. The composition has obvious actions on relieving pains and regulating the functions of the organism, and effectively treats equine cestodiasis; and compared with the western medicine treatment, the composition can shorten the recovery period and has the advantage of low tendency to relapse.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical engineering, in particular to a traditional Chinese medicine composition for treating equine taeniasis. Background technique [0002] Taeniasis is a common parasitic disease of equine animals, and the tapeworms parasitic in equine animals are mainly phyllocephalic tapeworms. Pyllocephalus is parasitic in the small intestine of horses, donkeys, mules and other animals, and occasionally the cecum is caused by the large phyllocephalic tapeworms, phyllocephalic phyllodes and dwarf paraphyllocephalic tapeworms of the phyllocephalic family. Occurs in various parts of our country, and phyllocephalus is more common. Pathogenicity and symptoms: Pectocephala phyllosum has the characteristic of clustering and parasitizing in the narrow part of the ileocecal stoma, usually dozens or hundreds of them, and they all use their suckers to adsorb the intestinal mucosa, causing mucosal inflammation and edema...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/77A61P33/10
Inventor 张肖军马玉萍陈艳光
Owner QINGDAO DERUI JUNFA BIOLOGY TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap